Accounts & AGM

Stay up to date with our recent press releases, Shareholder meetings and any investor related announcements.

Annual Report 2023 Notice of AGM & Proxy Forms

10 November 2023

Bioventix plc (AIM: BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for…

PRELIMINARY RESULTS FOR YEAR TO 30 JUNE 2023

30 October 2023

Director’s report and financial statements for the year ended 30th June 2023. To download this report as a PDF…

Unaudited Interim Results For The Six Months Ended 31 December 2022

3 April 2023

Interim Report and Financial Statements for the 6 months to 31 December 2022   To download this report as…

Results of AGM

8 December 2022

Bioventix plc (“Bioventix” or the “Company”)   Result of AGM Bioventix plc (AIM: BVXP) announces that at its Annual…

Annual Report 2022 Notice of AGM & Proxy Forms

8 November 2022

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications…

Preliminary results for year to 30 June 2022

24 October 2022

Director’s report and financial statements for the year ended 30th June 2022. To download this report as a PDF…

Interim Report and Financial Statements for the 6 months to 31 December 2021

28 March 2022

Interim Report and Financial Statements for the 6 months to 31 December 2021   To download this report as…

Results of AGM

10 December 2021

Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting (“AGM”), all resolutions put to shareholders were duly…

Annual Report 2021 Notice of AGM & Proxy Forms

11 November 2021

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications…

Preliminary results for year to 30 June 2021

18 October 2021

Director’s report and financial statements for the year ended 30th June 2021. To download this report as a PDF…

Interim Report and Accounts

29 March 2021

Unaudited interim results for the six months ended 31st December 2020

FINAL REPORT AND ACCOUNTS

16 November 2020

Director’s report and financial statements for the year ended 30th June 2020. To download this report as a PDF…